Related Experiment Video
Updated: May 25, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Review of inhaled nitric oxide in the pediatric cardiac surgery setting
Paul A Checchia1, Ronald A Bronicki, Brahm Goldstein
1Cardiovascular Intensive Care Unit, Texas Children’s Hospital, Baylor College of Medicine, 6621 Fannin, WT6-006, Houston, TX 77030, USA. pachecch@texaschildrens.org
Insights
Pulmonary hypertension (PH) complicates pediatric cardiac surgery. This review examines inhaled nitric oxide (iNO) for PH management post-surgery, highlighting limited pediatric trial data and discussing treatment considerations.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Pulmonary Medicine
Background:
- Congenital heart disease (CHD) surgical repair can lead to pulmonary hypertension (PH).
- Postoperative PH management is critical for improving outcomes in pediatric cardiac surgery patients.
- Inhaled nitric oxide (iNO) is a recognized treatment for PH.
Purpose of the Study:
- To review existing clinical studies on iNO for PH in pediatric cardiac surgery.
- To discuss general treatment considerations for iNO use in this patient population.
- To enhance understanding of iNO's clinical application after pediatric cardiac surgery.
Main Methods:
- Literature review of clinical studies.
- Analysis of iNO efficacy and safety data in pediatric PH post-cardiac surgery.
- Discussion of treatment strategies and considerations.
Main Results:
- Limited large-scale randomized, double-blind, placebo-controlled trials exist for pediatric patients.
- iNO is a standard of care, but evidence in pediatric cardiac surgery settings requires further investigation.
- Clinical data suggests potential benefits but highlights the need for more robust trials.
Conclusions:
- Further research, including large multicenter trials, is needed to solidify the role of iNO in pediatric cardiac surgery.
- Understanding treatment considerations is vital for optimizing iNO therapy in this complex patient group.
- Improved management of PH post-pediatric cardiac surgery can reduce morbidity and mortality.
Abstract:
Surgical intervention for congenital heart disease (CHD) can be complicated by pulmonary hypertension (PH), which increases morbidity, mortality, and medical burden. Consequently, postoperative management of PH is an important clinical consideration to improve outcomes. Inhaled nitric oxide (iNO) is a widely accepted standard of care for PH and has been studied in the context of cardiac surgery for CHD. However, large randomized, double-blind, placebo-controlled, multicenter clinical trials in pediatric patients are limited. This review will provide an overview of the clinical studies in this setting and will discuss general treatment considerations to facilitate a better understanding of the clinical use of iNO for PH after pediatric cardiac surgery.
Related Concept Videos
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils, connected...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Drug Delivery: Enteral Route
Drugs in...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
